Please rotate the screen for the best
viewing experience. Thank you.

This website was designed with newer technology in mind. Please update your current browser or switch to a recently updated browser. Thank you.

Menu
Filter
Founders Fund lead $36m Series-C Financing Round "We believe adoption of the Human Emulation System by drug developers is a scientific, commercial, and moral imperative.” read press release
Emulate and AstraZeneca Form Strategic Agreement “Organs-on-Chips technology has the potential to enhance and accelerate our ability to translate science into innovative medicines for patients” read press release

Insights, Talks, Data

See all articles from our team and community.

see all

News

November 5, 2018

BOSTON, Mass.

Emulate and Minifab Announce Strategic Manufacturing Partnership to Accelerate the Scaling and Commercialization of Emulate’s Human Emulation System™

Read More

July 24, 2018

BOSTON, Mass.

Founders Fund Leads $36 Million Financing Round in Emulate, Inc.

Read More

May 16, 2018

BOSTON, Mass.

Emulate, Inc. and AstraZeneca form strategic agreement to work side-by-side on Organs-on-Chips technology to improve prediction of human safety and efficacy of drug candidates

Read More

May 1, 2018

BOSTON, Mass.

Organ-Chips Accurately Model and Predict Thrombotic Side Effect Caused by Anti-CD154 Monoclonal Antibody hu5c8; Emulate Publishes Results of Collaborative Research with Janssen

Read More

February 20, 2018

BOSTON, Mass.

Emulate, Inc. Announces Strategic Partnership with Leading Pharmaceutical Company to Apply the ‘Human Emulation System’ as a Platform for Drug Discovery

Read More

February 20, 2018

Emulate and Takeda Partner to Use Intestine-Chip for New Drug Target Identification and Validation in Drug Development for GI Diseases

Read More

February 20, 2018

LOS ANGELES, Calif. & BOSTON, Mass.

Cedars-Sinai and Emulate, Inc. Announce Patient-on-a-Chip Program Using Stem Cells and Organs-on-Chips Technology for Precision Medicine

Read More

February 16, 2018

LOS ANGELES, Calif. & BOSTON, Mass.

Scientists from Cedars-Sinai and Emulate Produce Human Intestinal Lining That Re-Creates Living Tissue Inside Organ-Chip

Read More

June 20, 2017

BOSTON, Mass.

Emulate, Inc. Awarded Grant to Fund use of Human Emulation System aboard the International Space Station

Read More

May 23, 2017

BOSTON, Mass.

New Data from Emulate’s Asthma-on-Chip Presented at American Thoracic Society Annual Meeting

Read More

April 11, 2017

BOSTON, Mass.

FDA Signs Collaborative Agreement with Emulate, Inc. to Use Organs-on-Chips Technology as a Toxicology Testing Platform for Understanding How Products Affect Human Health and Safety

Read More

February 1, 2017

BOSTON, Mass.

Emulate, Inc. Adds New Capabilities to “Human Emulation System” for Studying Viral Diseases

Read More

October 27, 2016

BOSTON, Mass.

Emulate Adds New Capabilities to Human Lung-Chip System for Evaluating Safety of Inhaled Products, Airborne Pollutants, and Patient-Specific Responses to Drugs

Read More

October 20, 2016

Boston, Mass.

Emulate Announces Translational R&D Collaboration with Lawrence J. Ellison Institute for Transformative Medicine of USC

Read More

October 20, 2016

Boston, MA

Emulate Announces Strategic Collaboration with Covance to Integrate Organs-on-Chips Technology in Drug Evaluation

Read More

October 20, 2016

Boston, Mass.

Emulate, Inc. Expands Series B Financing to Augment Commercialization of Organs-on-Chips Technology into Lab-Ready ‘Human Emulation System’

Read More

July 12, 2016

Cambridge, MA

Seres Therapeutics and Emulate Announce Collaboration to Support the Development of Novel Microbiome Therapeutics for Inflammatory Bowel Disease and other Serious Conditions.

Read More

March 28, 2016

Boston, MA

Emulate, Inc. Secures $28 Million Series B Financing to Commercialize its Organs-on-Chips Technology into a Lab-Ready System; Enabling Human-Relevant R&D to Improve Drug Development and Consumer Product Design

Read More

February 12, 2016

Cambridge, MA

Emulate, Inc. Opens New Headquarters and Laboratories in the Seaport District of Boston’s Innovation Community

Read More

December 21, 2015

Cambridge, MA

Emulate Announces Expanded Collaboration with Merck to Use Organ-Chips in Drug Discovery and Development Process for Inflammatory Diseases

Read More

December 21, 2015

Cambridge, MA

Emulate’s Lung-Chip Demonstrates New Capabilities to Predict Human Lung Inflammation and Drug Responses in Asthma and COPD

Read More

October 22, 2015

Cambridge, MA

New Data with Brain-on-Chip for Neurodegenerative Disease from Collaborative Research by Emulate and Cedars-Sinai Presented at the Society for Neurosciences Annual Meeting

Read More

October 22, 2015

Cambridge, MA

Emulate, Inc. Awarded Michael J. Fox Foundation Grant to use Organs-on-Chips to Investigate Drug Candidates for Treatment of Parkinson’s Disease

Read More

June 23, 2015

Cambridge, MA

Emulate’s Human Organs-on-Chips Wins Design of the Year 2015

Read More

June 18, 2015

Cambridge, MA

Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process

Read More

May 21, 2015

Cambridge, MA

Emulate’s Organs-on-Chips Wins Best Product Design of the Year 2015

Read More

March 4, 2015

Cambridge, MA

Emulate’s Organs-on-Chips Receive Recognition for Innovative Design

Read More

July 28, 2014

Cambridge, MA

Emulate Launches to Commercialize Automated Human Organs-on-Chips Platform to Accelerate Drug Development, Detect Toxicities and Advance Personalized Medicine

Read More

Media Resources

Access our digital press kit for journalists and request an interview with our leadership team.

press kit